Inhaler
Latest AstraZeneca AB Patents:
- Substituted 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines, 5,7-dihydrofuro[3,4-d]pyrimidines, and pyrido[2,3-d]pyrimidines as KCC2 modulators
- Graph construction and visualization of multiplex immunofluorescence images
- Apparatus and method for evaluating physical strength or robustness of solid pharmaceutical dosage forms based on an impact strike test
- Chemical compounds
- Medical injector
Description
FIG. 1 is a perspective view of an inhaler with a mouthpiece in accordance with the invention.
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D448076
Type: Grant
Filed: May 15, 1998
Date of Patent: Sep 18, 2001
Assignee: AstraZeneca AB (Södertälje)
Inventor: Alfred von Schuckmann (Kevelaer)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Martin A. Farber
Application Number: 29/112,848
Type: Grant
Filed: May 15, 1998
Date of Patent: Sep 18, 2001
Assignee: AstraZeneca AB (Södertälje)
Inventor: Alfred von Schuckmann (Kevelaer)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Martin A. Farber
Application Number: 29/112,848
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;
